Comparison of axillary Exclusion versus No Exclusion on seroma formation after Modified Radical Mastectomy.

Objective: To determine the effectiveness of axillary exclusion technique versus no axillary exclusion in Modified Radical Mastectomy in terms of mean drain output. Study Design: Randomized Control Trial. Setting: Department of Surgery, Allied Hospital Faisalabad Pakistan. Period: 8th August, 2018 to 8th February, 2019. Methods: A request for authorization was made to the Hospital Ethical Review Committee. The research had 60 individuals in all who were admitted. General Surgery Department from outside the Allied Hospital in Faisalabad. For the sixty patients receiving modified radical mastectomy, written informed consent was obtained. A computer-generated database of random numbers was used to split them into two equal groups of thirty patients each at random. Following a modified radical mastectomy, group A received axillary exclusion, but group B did not. Total volume of accumulated fluid) following a modified radical mastectomy. After surgery, until the drain was removed, the total quantity of fluid collection in the drainage bag was recorded and compared across groups. Data was input into a template form. Results: In our study, the mean + SD was determined as 43.73+5.64 years in Group B. Of the two groups, 63.33% (n=19) in Group A and 70% (n=21) in Group B were between 41 and 70 years old, while 36.67% (n=11) in Group A and 30% (n=9) in Group B were between 20 and 40 years old. (First Table-I). Following a modified radical mastectomy with drainage, axillary exclusion procedures were compared with no exclusion, and the results indicated that the mean total drainage output (+SD) in Group B was 642.1 ml (+117.06). (Table-II). The total volume of seroma fluid drained between the two groups was significantly lower, as indicated by the p value of ˂0.001. Conclusion: In comparison to individuals who do not undergo axillary exclusion, we find that axillary exclusion procedures considerably reduce drainage expense in patients undergoing modified radical mastectomy.